BioRestorative Therapies, Inc. (BRTX) Financials
BRTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 13.8 million | 975033 |
| 2023-06-30 | 13.3 million | 896433 |
| 2023-03-31 | 14.1 million | 593927 |
| 2022-12-31 | 16.4 million | 602619 |
BRTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -1.2 million | 1.5 million |
| 2023-06-30 | -1.2 million | 1.5 million |
| 2023-03-31 | -2.4 million | 3.3 million |
| 2022-12-31 | -1.8 million | 3.1 million |
BRTX Net Income
No data available :(
BRTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 12.2 million | - | 198724 |
| 2023-06-30 | 11.6 million | - | 234060 |
| 2023-03-31 | 12.4 million | - | 268357 |
| 2022-12-31 | 14.7 million | - | 301645 |
BRTX Shares Outstanding
BRTX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 11948 | 874824 | 2.3 million | - |
| 2023-06-30 | 29049 | 967891 | 2.2 million | - |
| 2023-03-31 | 60022 | 1.5 million | 4.3 million | - |
| 2022-12-31 | 217581 | 673621 | 4.0 million | -714 |
BRTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 30700 | 42145 |
| 2023-06-30 | 64500 | 70537 |
| 2023-03-31 | 31300 | 68362 |
| 2022-12-31 | 3700 | 104882 |
BRTX
Price: $1.26
52 week price:
Earnings Per Share: -4.03 USD
P/E Ratio: -0.36
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 19500
Market Capitalization: 8.6 million